Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Centessa Pharmaceuticals ADR | CNTA | Nov 19, 2024 | 16.83 | +4.53 |
Centrais Electricas Brasileiras B ADR | EBR-B | Nov 19, 2024 | 6.91 | +0.14 |
Centrais Eletricas Brasileiras ADR | EBR | Nov 19, 2024 | 6.20 | -0.16 |
Central Garden & Pet | CENT | Nov 19, 2024 | 36.66 | -0.97 |
Central Garden & Pet A | CENTA | Nov 19, 2024 | 31.44 | -1.01 |
Central Pacific Financial | CPF | Nov 19, 2024 | 30.77 | -0.61 |
Central Plains Bancshares | CPBI | Nov 19, 2024 | 14.52 | 0.00 |
Central Puerto ADR | CEPU | Nov 19, 2024 | 13.69 | +2.16 |
Central Securities | CET | Nov 19, 2024 | 46.33 | +0.22 |
Centrus Energy A | LEU | Nov 19, 2024 | 68.50 | -10.41 |
Centuri Holdings | CTRI | Nov 19, 2024 | 20.85 | +1.36 |
Centurion Acquisition | ALFUU | Nov 19, 2024 | 10.27 | 0.00 |
Century Aluminium | CENX | Nov 19, 2024 | 22.96 | +3.24 |
Century Casinos | CNTY | Nov 19, 2024 | 4.25 | -0.93 |
Century Communities | CCS | Nov 19, 2024 | 85.80 | +0.89 |
Century Therapeutics | IPSC | Nov 19, 2024 | 1.28 | +2.40 |
Cepton | CPTN | Nov 19, 2024 | 3.12 | -0.16 |
Ceragon Networks | CRNT | Nov 19, 2024 | 3.12 | 0.00 |
Cerence | CRNC | Nov 19, 2024 | 2.97 | +1.37 |
CeriBell | CBLL | Nov 19, 2024 | 25.57 | 0.00 |
CERo Therapeutics | CERO | Nov 19, 2024 | 0.26 | +7.68 |
Certara | CERT | Nov 19, 2024 | 9.88 | -1.10 |
Cerus | CERS | Nov 19, 2024 | 1.68 | +0.60 |
CervoMed | CRVO | Nov 19, 2024 | 10.08 | -3.17 |
CEVA | CEVA | Nov 19, 2024 | 28.28 | +3.06 |
CF Acquisition VII A | CFFS | Nov 19, 2024 | 11.21 | +0.18 |
CF Bankshares | CFBK | Nov 19, 2024 | 27.23 | 0.00 |
CF Industries | CF | Nov 19, 2024 | 87.54 | +0.18 |
CFSB Bancorp | CFSB | Nov 19, 2024 | 6.66 | -1.77 |
CG Oncology | CGON | Nov 19, 2024 | 32.80 | -1.23 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.